ViRexx is an Edmonton, Alberta based biotechnology company focused on the development of novel therapeutic products for the treatment of certain cancers and specified chronic viral infections. ViRexx's most advanced programs include drug candidates for the treatment of ovarian cancer, chronic hepatitis B and C and solid tumors.

Contact Information

8223 Roper Road
Edmonton, ABT6E6S4

tel: 780-433-4411
fax: 780-436-0068


Investor Relations



Exchange: AMEX
Industry: Biotechnology
Market Cap: $4.3M

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.